31 related articles for article (PubMed ID: 21328336)
1. Renal cancer secretome induces migration of mesenchymal stromal cells.
Popławski P; Zarychta-Wiśniewska W; Burdzińska A; Bogusławska J; Adamiok-Ostrowska A; Hanusek K; Rybicka B; Białas A; Kossowska H; Iwanicka-Rokicka R; Koblowska M; Pączek L; Piekiełko-Witkowska A
Stem Cell Res Ther; 2023 Aug; 14(1):200. PubMed ID: 37563650
[TBL] [Abstract][Full Text] [Related]
2. Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.
Mayo V; Bowles AC; Wubker LE; Ortiz I; Cordoves AM; Cote RJ; Correa D; Agarwal A
Exp Biol Med (Maywood); 2021 Apr; 246(8):971-985. PubMed ID: 33210551
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cell polarization by the Na+-K+-ATPase-associated protein FXYD5 (dysadherin).
Lubarski I; Asher C; Garty H
Am J Physiol Cell Physiol; 2014 Jun; 306(11):C1080-8. PubMed ID: 24717576
[TBL] [Abstract][Full Text] [Related]
4. Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.
Lee YK; Lee SY; Park JR; Kim RJ; Kim SR; Roh KJ; Nam JS
Cancer Sci; 2012 Jul; 103(7):1280-9. PubMed ID: 22494103
[TBL] [Abstract][Full Text] [Related]
5. Fxyd5 activates the NF‑κB pathway and is involved in chondrocytes inflammation and extracellular matrix degradation.
Song L; Li X; Sun Q; Zhao Y
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35191523
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.
Makino T; Izumi K; Hiratsuka K; Kano H; Shimada T; Nakano T; Kadomoto S; Naito R; Iwamoto H; Yaegashi H; Shigehara K; Kadono Y; Nakata H; Saito Y; Nakagawa-Goto K; Sakai N; Iwata Y; Wada T; Mizokami A
Sci Rep; 2021 Jan; 11(1):675. PubMed ID: 33436830
[TBL] [Abstract][Full Text] [Related]
7. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
8. FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.
Besso MJ; Rosso M; Lapyckyj L; Moiola CP; Matos ML; Mercogliano MF; Schillaci R; Reventos J; Colas E; Gil-Moreno A; Wernicke A; Orti R; Vazquez-Levin MH
Front Oncol; 2019; 9():1306. PubMed ID: 31867269
[No Abstract] [Full Text] [Related]
9. Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis.
Mannavola F; Tucci M; Felici C; Passarelli A; D'Oronzo S; Silvestris F
J Transl Med; 2019 Jul; 17(1):230. PubMed ID: 31324252
[TBL] [Abstract][Full Text] [Related]
10. Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Küper C; Beck FX; Neuhofer W
Oncol Lett; 2016 Sep; 12(3):2201-2209. PubMed ID: 27602164
[TBL] [Abstract][Full Text] [Related]
11. FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease.
Lubarski Gotliv I
Front Cell Dev Biol; 2016; 4():26. PubMed ID: 27066483
[TBL] [Abstract][Full Text] [Related]
12. FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.
Lubarski-Gotliv I; Asher C; Dada LA; Garty H
J Biol Chem; 2016 May; 291(21):11072-82. PubMed ID: 27006401
[TBL] [Abstract][Full Text] [Related]
13. FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
Raman P; Purwin T; Pestell R; Tozeren A
Cancer Inform; 2015; 14():113-9. PubMed ID: 26494976
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.
Von Roemeling CA; Marlow LA; Radisky DC; Rohl A; Larsen HE; Wei J; Sasinowska H; Zhu H; Drake R; Sasinowski M; Tun HW; Copland JA
Oncotarget; 2014 Jul; 5(14):5320-34. PubMed ID: 24979721
[TBL] [Abstract][Full Text] [Related]
15. Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer.
Georgolios A; Eleftheriadou A; Batistatou A; Charalabopoulos K
Med Oncol; 2012 Sep; 29(3):1463-7. PubMed ID: 22105147
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.
Schüler Y; Lee-Thedieck C; Geiger K; Kaiser T; Ino Y; Aicher WK; Klein G
Int J Cancer; 2012 Jan; 130(2):288-99. PubMed ID: 21328336
[TBL] [Abstract][Full Text] [Related]
17. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
Nam JS; Kang MJ; Suchar AM; Shimamura T; Kohn EA; Michalowska AM; Jordan VC; Hirohashi S; Wakefield LM
Cancer Res; 2006 Jul; 66(14):7176-84. PubMed ID: 16849564
[TBL] [Abstract][Full Text] [Related]
18. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
Pan T; Lin SC; Yu KJ; Yu G; Song JH; Lewis VO; Bird JE; Moon B; Lin PP; Tannir NM; Jonasch E; Wood CG; Gallick GE; Yu-Lee LY; Lin SH; Satcher RL
Neoplasia; 2018 Jan; 20(1):32-43. PubMed ID: 29190493
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
